Skip to main content
SpringerLink
Log in

Bioethical aspects of regenerative and reproductive medicine

  • Feature: Regenerative Medicine
  • Published:
Human Cell Aims and scope Submit manuscript

Abstract

The birth announced in 1997 of Dolly, the lamb cloned from the somatic mammary cells of an adult ewe, and the discovery of human embryonic stem cells in 1998 have been the most exciting developments in the biological sciences in the past decade. Reproductive somatic cell nuclear transfer (SCNT) in additional species has been inefficient in that relatively few births, harmful side effects and high fetal and neonatal death rates have resulted from many attempts. Ongoing debates about the ethics of reproductive SCNT have revealed that some researchers regard human reproductive SCNT as morally unacceptable in all circumstances, others see merit in reproductive SCNT in certain circumstances and others await more information before making judgment about the ethical status of the procedure. Regenerative medicine and emerging biotechnologies started to revolutionize the practice of medicine. Advances in stem cell biology, including embryonic and postnatal somatic stem cells, have made the prospect of tissue regeneration a potential reality. Mammal cloning experiments have provided new impetus to the prospect of regenerative medicine through stem cell research. The procedure of SCNT could be used to create the raw material to replace defective or senescent tissue as a natural extension of the biology of stem cells. Researchers working in reproductive medicine should consider the potential hope given to many patients against the requisite and ethically contentious creation of human blastocysts for therapeutic intent.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Wilmut I, Schnieke AE, McWhir J et al. Viable offspring derived from fetal and adult mammalian cells. Nature 1997; 385: 810–13.

    Article  CAS  PubMed  Google Scholar 

  2. Thomson JA, Itskovitz-Eldor J, Shapiro SS et al. Embryonic stem cell lines derived from human blastcysts. Science 1998; 282: 1145–7.

    Article  CAS  PubMed  Google Scholar 

  3. Donovan PJ, Gearhart J. The end of the beginning for pluripotent stem cells. Nature 2001; 414: 92–7.

    Article  CAS  PubMed  Google Scholar 

  4. Surani MA. Reprogramming of genome function through epigenetic inheritance. Nature 2001; 414: 122–8.

    Article  CAS  PubMed  Google Scholar 

  5. Reubinoff BE, Pera MF, Fong CY et al. Embryonic stem cell lines from human blastocysts: somatic differentiation in vitro. Nat Biotechnol 2000; 18: 399–404.

    Article  CAS  PubMed  Google Scholar 

  6. Holm S. Going to the roots of the stem cell controversy. Bioethics 2002; 16: 493–507.

    Article  PubMed  Google Scholar 

  7. Doerflinger RM. The ethics of funding embryonic stem cell research: a Catholic viewpoint. Kennedy Inst Ethics J 1999; 9: 137–50.

    Article  PubMed  Google Scholar 

  8. Shamblott MJ, Axelman J, Wang S et al. Derivation of pluripotent stem cells from cultured human primordial germ cells. Proc Natl Acad Sci USA 1998; 95: 13726–31.

    Article  CAS  PubMed  Google Scholar 

  9. McGee G, Gaplan A. The ethics and politics of small sacrifices in stem cell research. Kennedy Inst Ethics J 1999; 9: 151–8.

    Article  PubMed  Google Scholar 

  10. The Ethics Committee of the American Society for Reproductive Medicine. Human somatic cell nuclear transfer (cloning). Fertil Steril 2000; 74: 873–6.

    Article  Google Scholar 

  11. Tamashiro KL, Wakayama T, Akutsu H et al. Cloned mice have an obese phenotype not transmitted to their offspring. Nat Med 2002; 8: 262–7.

    Article  CAS  PubMed  Google Scholar 

  12. Renard JP, Chastant S, Chesne P et al. Lymphoid hypoplasia and somatic cloning. Lancet 1999; 353: 1489–91.

    Article  CAS  PubMed  Google Scholar 

  13. Bowring F. Therapeutic and reproductive cloning: a critique. Soc Sci Med 2004; 58: 401–9.

    Article  PubMed  Google Scholar 

  14. Evans M. Ethical sourcing of human embryonic stem cells — rational solutions? Nat Rev Mol Cell Biol 2005; 6: 663–7.

    Article  CAS  PubMed  Google Scholar 

  15. Hwang WS, Ryu YJ, Park JH et al. Evidence of a pluripotent human embryonic stem cell line derived from a cloned blastocyst. Science 2004; 303: 1669–74.

    Article  CAS  PubMed  Google Scholar 

  16. Martin MJ, Muotri A, Gage F et al. Human embryonic stem cells express an immunogenic nonhuman sialic acid. Nat Med 2005; 11: 228–32.

    Article  CAS  PubMed  Google Scholar 

  17. Hwang WS, Roh SI, Lee BC et al. Patient-specific embryonic stem cells derived from human SCNT blastcysts. Sicence 2005; 308: 1777–83.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Obstetrics and Gynecology, Keio University School of Medicine, Shinjuku, 160-8582, Tokyo, Japan

    Yasunori Yoshimura

Authors
  1. Yasunori Yoshimura
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yasunori Yoshimura.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yoshimura, Y. Bioethical aspects of regenerative and reproductive medicine. Hum Cell 19, 83–86 (2006). https://doi.org/10.1111/j.1749-0774.2006.00009.x

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1111/j.1749-0774.2006.00009.x

Key words

Search

Navigation